Enter Your Practice Information

Yes No

Yes No


Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.


  Sign up now for:
Become a Member

Journal July 2010 (Vol 32, No 7)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Fluoroquinolones: Then and Now

1. The first fluoroquinolone to be approved for use in veterinary medicine was
2. What is the primary mechanism of action for fluoroquinolones?
3. Approximately 10% to 40% of enrofloxacin is metabolized to ________ in dogs.
4. ________ is a potential adverse effect of fluoroquinolone administration in cats, but not in dogs.
5. What is the recommended dosage of enrofloxacin in cats?
6. Fluoroquinolones are most effective against ________ bacteria.
7. ________ is metabolized via the glucuronidation pathway and therefore should not be used in cats.
8. The drug concentration defined as allowing no visible residual bacterial growth is known as the
9. What type of resistance, long thought to not occur with fluoroquinolones, has recently been discovered in clinical isolates?
10. In cats, retinal degeneration with fluoroquinolone use is associated with all of the following except
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More